To begin to delineate BART1 functions during EBV infection, genes changed in the same direction (P values and false discovery rates [FDR] of <0.05) in the AGS-EBV and BART samples versus the pc control were analyzed for Gene Ontology (GO) enrichment in Partek (Table S2). The gene discussed is ARL2BP; the disease is Epstein-Barr virus infection.